DE69703388T2 - Verfahren zur herstellung von phosphodiesterase iv inhibitoren - Google Patents

Verfahren zur herstellung von phosphodiesterase iv inhibitoren

Info

Publication number
DE69703388T2
DE69703388T2 DE69703388T DE69703388T DE69703388T2 DE 69703388 T2 DE69703388 T2 DE 69703388T2 DE 69703388 T DE69703388 T DE 69703388T DE 69703388 T DE69703388 T DE 69703388T DE 69703388 T2 DE69703388 T2 DE 69703388T2
Authority
DE
Germany
Prior art keywords
phosphodiesterase
inhibitors
producing
producing phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69703388T
Other languages
English (en)
Other versions
DE69703388D1 (de
Inventor
Woo-Baeg Choi
R Churchill
E Lynch
J Reider
P Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614329.2A external-priority patent/GB9614329D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69703388D1 publication Critical patent/DE69703388D1/de
Application granted granted Critical
Publication of DE69703388T2 publication Critical patent/DE69703388T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69703388T 1996-05-08 1997-05-05 Verfahren zur herstellung von phosphodiesterase iv inhibitoren Expired - Fee Related DE69703388T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1683996P 1996-05-08 1996-05-08
GBGB9614329.2A GB9614329D0 (en) 1996-07-08 1996-07-08 Method of preparing phosphodiesterase IV
PCT/US1997/007457 WO1997042172A1 (en) 1996-05-08 1997-05-05 Method of preparing phosphodiesterase iv inhibitors

Publications (2)

Publication Number Publication Date
DE69703388D1 DE69703388D1 (de) 2000-11-30
DE69703388T2 true DE69703388T2 (de) 2001-05-17

Family

ID=26309666

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69703388T Expired - Fee Related DE69703388T2 (de) 1996-05-08 1997-05-05 Verfahren zur herstellung von phosphodiesterase iv inhibitoren

Country Status (13)

Country Link
EP (1) EP0912517B1 (de)
JP (1) JP2000510120A (de)
AR (1) AR007041A1 (de)
AT (1) ATE197148T1 (de)
AU (1) AU707289B2 (de)
CA (1) CA2253279A1 (de)
DE (1) DE69703388T2 (de)
DK (1) DK0912517T3 (de)
ES (1) ES2151728T3 (de)
GR (1) GR3034674T3 (de)
PT (1) PT912517E (de)
TW (1) TW418192B (de)
WO (1) WO1997042172A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (de) * 1992-12-23 1995-11-21 Celltech Ltd
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process

Also Published As

Publication number Publication date
AU2825297A (en) 1997-11-26
AU707289B2 (en) 1999-07-08
DE69703388D1 (de) 2000-11-30
WO1997042172A1 (en) 1997-11-13
TW418192B (en) 2001-01-11
JP2000510120A (ja) 2000-08-08
EP0912517B1 (de) 2000-10-25
ATE197148T1 (de) 2000-11-15
EP0912517A1 (de) 1999-05-06
CA2253279A1 (en) 1997-11-13
AR007041A1 (es) 1999-10-13
GR3034674T3 (en) 2001-01-31
ES2151728T3 (es) 2001-01-01
PT912517E (pt) 2001-03-30
DK0912517T3 (da) 2000-11-20

Similar Documents

Publication Publication Date Title
DE59708146D1 (de) Verfahren zur herstellung von polyalkoholen
ATE246194T1 (de) Verfahren zur herstellung von sildenafil
DE69618020T2 (de) Verfahren zur herstellung von hydrofluorethern
DE69726581D1 (de) Verfahren zur herstellung von cyclohexandimethanol
ATE194850T1 (de) Verfahren zur herstellung von peroxiperfluoropolyxyalkylene
DE59705109D1 (de) Verfahren zur herstellung von arylcyanaten
DE69706828T2 (de) Verfahren zur herstellung von purinderivaten
DE69712602T2 (de) Verfahren zur herstellung von tensiden
DE59709989D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
ATE198318T1 (de) Verfahren zur herstellung von n-acetonylbenzamide
DE59704683D1 (de) Verfahren zur herstellung von 6-aminocapronitril
ATE221056T1 (de) Verfahren zur herstellung von benzisothiazolin-3- onen
ATE225797T1 (de) Verfahren zur herstellung von oxazaphosphorin-2- aminen
DE59704682D1 (de) Verfahren zur herstellung von 6-aminocapronitril
DE69733152D1 (de) Verfahren zur herstellung von tetrazolylbenzopyranen
DE69708137D1 (de) Verfahren zur herstellung von difluormethan
DE69720077D1 (de) Verfahren zur herstellung von para-fluorphenol
DE59805432D1 (de) Verfahren zur herstellung von 2-cyclododecyl-1-propanol
DE59811807D1 (de) Verfahren zur herstellung von chlorbenzoxazolen
DE59802548D1 (de) Verfahren zur herstellung von webware
ATE237607T1 (de) Verfahren zur herstellung von 3-ispchromanon
DE69802546D1 (de) Verfahren zur herstellung von tuftingware
ATE197148T1 (de) Verfahren zur herstellung von phosphodiesterase iv inhibitoren
ATE236138T1 (de) Verfahren zur herstellung von n-alkylammonium- acetonitrlverbindungen
ATE224383T1 (de) Verfahren zur herstellung von 3-isochromanon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee